Mucositis Clinical Trials

52 recruitingLast updated: June 18, 2026

There are 52 actively recruiting mucositis clinical trials across 15 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Chengdu, Sichuan, China, Guangzhou, Guangdong, China, Shanghai, Shanghai Municipality, China. Updated daily from ClinicalTrials.gov.


Mucositis Trials at a Glance

52 actively recruiting trials for mucositis are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Chengdu, Guangzhou, and Shanghai. Lead sponsors running mucositis studies include Nanfang Hospital, Southern Medical University, West China Hospital, and Ain Shams University.

Browse mucositis trials by phase

Treatments under study

About Mucositis Clinical Trials

Looking for clinical trials for Mucositis? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mucositis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mucositis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 52 trials

Recruiting

Occurrence of Peri-Implant Complications: A Multifactorial Cross-Sectional Study

Peri-Implantitis and Peri-implant Mucositis
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain150 enrolled1 locationNCT07638969
Recruiting
Phase 3

Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid

Nasopharyngeal Cancinoma (NPC)Radiation-induced Oral Mucositis
Sun Yat-sen University386 enrolled16 locationsNCT07311772
Recruiting
Phase 2

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

MucositisStomatitis
Niels Fristrup100 enrolled2 locationsNCT03581773
Recruiting
Not Applicable

Peri-implantitis Implantoplasty Treatment

Peri-implantitisPeri-implant mucositis
University of Oslo35 enrolled2 locationsNCT04052373
Recruiting
Phase 2

Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

Oral MucositisHematopoietic Stem Cell TransplantationStomatitis+1 more
The First Affiliated Hospital of Soochow University22 enrolled1 locationNCT07400328
Recruiting
Not Applicable

Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.

PainHead and Neck CancerQuality of Life+6 more
Mucosa Innovations, S.L.63 enrolled1 locationNCT05635929
Recruiting
Phase 4

Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy

Oral Mucositis Due to Chemotherapy
Woman's45 enrolled1 locationNCT07287826
Recruiting
Phase 2

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

Radiotherapy-induced Oral Mucositis
West China Hospital128 enrolled1 locationNCT07339774
Recruiting
Phase 2

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

Radiation-induced Oral Mucositis
West China Hospital118 enrolled1 locationNCT07282483
Recruiting
Not Applicable

Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis

Chemotherapy induced oral mucositisHead and Neck NeoplasmsOral Mucositis
University of Pavia50 enrolled1 locationNCT07491536
Recruiting
Not Applicable

Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation

Oral Mucositis
Ain Shams University14 enrolled1 locationNCT07436650
Recruiting
Not Applicable

Prevention of Oral Mucositis in Head and Neck Cancer.

Oral Mucositis
Catholic University of the Sacred Heart130 enrolled1 locationNCT05853692
Recruiting
Phase 2

Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis

Radiation-induced Oral MucositisRadiodermatitis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University160 enrolled1 locationNCT07029178
Recruiting
Not Applicable

Trehalose vs Glycine Air-Polishing in Peri-Implant Mucositis Treatment

Peri-implant mucositis
University of Pavia40 enrolled1 locationNCT07140146
Recruiting
Not Applicable

Impact of Keratinized Mucosa Augmentation on Treatment Outcomes of Peri-implant Mucositis

Peri-implant mucositis
Biruni University48 enrolled1 locationNCT06305000
Recruiting
Phase 3

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

Mucositis Oral
Gustave Roussy, Cancer Campus, Grand Paris315 enrolled5 locationsNCT03983369
Recruiting
Not Applicable

A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation Treatment

Oral Mucositis
Peter MacCallum Cancer Centre, Australia30 enrolled1 locationNCT07387978
Recruiting
Not Applicable

F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)

CancerOral MucositisPeriodontal Diseases
Georgetown University100 enrolled1 locationNCT06315855
Recruiting
Not Applicable

AI-Assisted Colorimetric Diagnosis of Peri-Implant Mucosal Erythema

Peri-implant mucositis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University200 enrolled1 locationNCT07349095
Recruiting
Phase 2

Coconut Oil to Prevent Mouth Sores in Pediatric Patients Receiving High Dose Chemotherapy

Oral Mucositis
Wake Forest University Health Sciences60 enrolled1 locationNCT05441813